Nickolaj Jacob Petersen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nickolaj Jacob Petersen has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Stig Pedersen-Bjergaard
University of Oslo
19 shared publications Steen Honoré Hansen
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, 2100 Copenhagen, Denmark
13 shared publicationsHenrik Jensen
Department of Pharmacy, Faculty of Health and Medical Sciences , University of Copenhagen , Universitetsparken 2 , DK-2100 Copenhagen Ø , Denmark
12 shared publications- Jörg Peter Kutter
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
10 shared publications - Henrik Jensen
FIDA Biosystems ApS Søborg 2860 Denmark
7 shared publications - Jesper Østergaard
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark; LEO Foundation Center for Cutaneous Drug Delivery, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
7 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Elsevier in Advances in Sample Preparation
- Vol. 20
Electromembrane extraction of basic pharmaceuticals from biological matrices using a micro-pillar stabilized liquid membrane
- 6 October 2026
- Published by Elsevier in Advances in Sample Preparation
- Vol. 20
Open AccessElectromembrane extraction of basic pharmaceuticals from biological matrices using a micro-pillar stabilized liquid membrane
- Open Access
- 6 March 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 418 (11) , 3251-3262
Microfluidic device for electromembrane extraction with a micro-pillar stabilized liquid membrane
Electromembrane extraction (EME) is a microextraction technique where charged analytes are transferred across a liquid membrane, under the influence of an electrical field, and enables selective and efficient sample cleanup. In this paper, we present for the first time a microfluidic device for electromembrane extraction where the liquid membrane was held in place by rows of micro-pillars. This design allows rapid membrane replacement, low-voltage extractions, and extended reuse, addressing key limitations of conventional EME formats. The microchip was fabricated in a stoichiometric thiol-ene polymer, offering a balance between hydrophobic and hydrophilic properties and supporting controlled flow of both aqueous and organic phases. Lidocaine was selected as the test substance for the experiments. Extraction parameters were optimized, and with a sample flow of 0.5 µL min−1, acceptor flow of 2.0 µL min−1, 0.1 µL 2-nitrophenyl octyl ether (NPOE) as the liquid membrane, and a 10-min extraction time, recoveries up to 50% were obtained. Linearity was demonstrated from 5 to 20 µg mL−1 (R2≈0.99), repeatability was acceptable (16.0% RSD), and carryover was minimal (1.3%). The system remained stable for at least 60 min of continuous extraction, and the liquid membrane could easily be replenished without chip disassembly. The miniaturized design and low solvent consumption yielded a high AGREEprep greenness score of 0.79, confirming the greenness and sustainability of the method. This work is a first step towards a versatile, reusable, and sustainable EME microchip and represents a key step towards a highly flexible device with potential for on-site analytical applications. Graphical abstract
- 6 March 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 418 (11) , 3251-3262
Open AccessMicrofluidic device for electromembrane extraction with a micro-pillar stabilized liquid membrane
Electromembrane extraction (EME) is a microextraction technique where charged analytes are transferred across a liquid membrane, under the influence of an electrical field, and enables selective and efficient sample cleanup. In this paper, we present for the first time a microfluidic device for electromembrane extraction where the liquid membrane was held in place by rows of micro-pillars. This design allows rapid membrane replacement, low-voltage extractions, and extended reuse, addressing key limitations of conventional EME formats. The microchip was fabricated in a stoichiometric thiol-ene polymer, offering a balance between hydrophobic and hydrophilic properties and supporting controlled flow of both aqueous and organic phases. Lidocaine was selected as the test substance for the experiments. Extraction parameters were optimized, and with a sample flow of 0.5 µL min−1, acceptor flow of 2.0 µL min−1, 0.1 µL 2-nitrophenyl octyl ether (NPOE) as the liquid membrane, and a 10-min extraction time, recoveries up to 50% were obtained. Linearity was demonstrated from 5 to 20 µg mL−1 (R2≈0.99), repeatability was acceptable (16.0% RSD), and carryover was minimal (1.3%). The system remained stable for at least 60 min of continuous extraction, and the liquid membrane could easily be replenished without chip disassembly. The miniaturized design and low solvent consumption yielded a high AGREEprep greenness score of 0.79, confirming the greenness and sustainability of the method. This work is a first step towards a versatile, reusable, and sustainable EME microchip and represents a key step towards a highly flexible device with potential for on-site analytical applications. Graphical abstract
- Open Access
- 27 March 2019
- Published by Wiley in Electrophoresis
- Vol. 40 (18-19) , 2514-2521
On‐chip electromembrane extraction of acidic drugs
In the present work, a new supported liquid membrane (SLM) has been developed for on‐chip electromembrane extraction of acidic drugs combined with HPLC or CE, providing significantly higher stability than those reported up to date. The target analytes are five widely used non‐steroidal anti‐inflammatory drugs (NSAIDs): ibuprofen (IBU), diclofenac (DIC), naproxen (NAX), ketoprofen (KTP) and salicylic acid (SAL). Two different microchip devices were used, both consisted basically of two poly(methyl methacrylate) (PMMA) plates with individual channels for acceptor and sample solutions, respectively, and a 25 µm thick porous polypropylene membrane impregnated with the organic solvent in between. The SLM consisting of a mixture of 1‐undecanol and 2‐nitrophenyl octyl ether (NPOE) in a ratio 1:3 was found to be the most suitable liquid membrane for the extraction of these acidic drugs under dynamic conditions. It showed a long‐term stability of at least 8 hours, a low system current around 20 µA, and recoveries over 94% for the target analytes. NPOE was included in the SLM to significantly decrease the extraction current compared to pure 1‐undecanol, while the extraction properties was almost unaffected. Moreover, it has been successfully applied to the determination of the target analytes in human urine samples, providing high extraction efficiency.
- 27 March 2019
- Published by Wiley in Electrophoresis
- Vol. 40 (18-19) , 2514-2521
Open AccessOn‐chip electromembrane extraction of acidic drugs
In the present work, a new supported liquid membrane (SLM) has been developed for on‐chip electromembrane extraction of acidic drugs combined with HPLC or CE, providing significantly higher stability than those reported up to date. The target analytes are five widely used non‐steroidal anti‐inflammatory drugs (NSAIDs): ibuprofen (IBU), diclofenac (DIC), naproxen (NAX), ketoprofen (KTP) and salicylic acid (SAL). Two different microchip devices were used, both consisted basically of two poly(methyl methacrylate) (PMMA) plates with individual channels for acceptor and sample solutions, respectively, and a 25 µm thick porous polypropylene membrane impregnated with the organic solvent in between. The SLM consisting of a mixture of 1‐undecanol and 2‐nitrophenyl octyl ether (NPOE) in a ratio 1:3 was found to be the most suitable liquid membrane for the extraction of these acidic drugs under dynamic conditions. It showed a long‐term stability of at least 8 hours, a low system current around 20 µA, and recoveries over 94% for the target analytes. NPOE was included in the SLM to significantly decrease the extraction current compared to pure 1‐undecanol, while the extraction properties was almost unaffected. Moreover, it has been successfully applied to the determination of the target analytes in human urine samples, providing high extraction efficiency.
- 2 July 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (15) , 9322-9329
Nanoliter-Scale Electromembrane Extraction and Enrichment in a Microfluidic Chip
This paper reports for the first time nanoliter-scale electromembrane extraction (nanoliter-scale EME) in a microfluidic device. Six basic drug substances (model analytes) were extracted from 70 μL samples of human whole blood, plasma, or urine, through a supported liquid membrane (SLM) of 2-nitrophenyl octyl ether (NPOE) and into 6 nL of 10 mM formic acid as acceptor solution. A DC potential of 15 V was applied across the SLM, and served as driving force for the extraction. The cathode was located in the acceptor solution. Due to the small area of the SLM (0.06 mm2), the system provided soft extraction with recoveries < 1 % for the 70 µL samples. Due to the large sample-to-acceptor volume ratio, analytes were enriched in the acceptor solution. Enrichment capacity was 6-7-fold per minute, and after 60 minutes operation most of the model analytes were enriched by a factor of approximately 400. Because of the SLM and the direction of the applied electrical field, a substantial sample clean-up was obtained. The chips were based on thiol-ene polymers, and the soft lithography fabrication procedure and the materials were selected in such a way that future mass production should be feasible. The chip-to-chip variability was within 23 % RSD (and less than 10 % in most cases) with respect to extraction recovery. Our findings have verified that nanoliter-scale EME is highly feasible and provides reliable data, and for future studies the concept should be tested for applicability in connection with in vitro micro-physiological systems, organ-on-a-chip systems, and point-of-care diagnostics. These are potential areas where the combination of soft extraction and high enrichment from limited sample volumes is required for reliable analytical measurements.
- 2 July 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (15) , 9322-9329
Nanoliter-Scale Electromembrane Extraction and Enrichment in a Microfluidic Chip
This paper reports for the first time nanoliter-scale electromembrane extraction (nanoliter-scale EME) in a microfluidic device. Six basic drug substances (model analytes) were extracted from 70 μL samples of human whole blood, plasma, or urine, through a supported liquid membrane (SLM) of 2-nitrophenyl octyl ether (NPOE) and into 6 nL of 10 mM formic acid as acceptor solution. A DC potential of 15 V was applied across the SLM, and served as driving force for the extraction. The cathode was located in the acceptor solution. Due to the small area of the SLM (0.06 mm2), the system provided soft extraction with recoveries < 1 % for the 70 µL samples. Due to the large sample-to-acceptor volume ratio, analytes were enriched in the acceptor solution. Enrichment capacity was 6-7-fold per minute, and after 60 minutes operation most of the model analytes were enriched by a factor of approximately 400. Because of the SLM and the direction of the applied electrical field, a substantial sample clean-up was obtained. The chips were based on thiol-ene polymers, and the soft lithography fabrication procedure and the materials were selected in such a way that future mass production should be feasible. The chip-to-chip variability was within 23 % RSD (and less than 10 % in most cases) with respect to extraction recovery. Our findings have verified that nanoliter-scale EME is highly feasible and provides reliable data, and for future studies the concept should be tested for applicability in connection with in vitro micro-physiological systems, organ-on-a-chip systems, and point-of-care diagnostics. These are potential areas where the combination of soft extraction and high enrichment from limited sample volumes is required for reliable analytical measurements.
- 10 May 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (11) , 6413-6418
UV–vis Imaging of Piroxicam Supersaturation, Precipitation, and Dissolution in a Flow-Through Setup
Evaluation of drug precipitation is important in order to address challenges regarding low and variable bioavail-ability of poorly water-soluble drugs, to assess potential risk of patient safety with infusion therapy and to explore injectable in situ suspension-forming drug delivery systems. Generally, drug precipitation is assessed in vitro through solution concentra-tion analysis methods. Dual-wavelength UV-Vis imaging is a novel imaging technique which may provide an opportunity for simultaneously monitoring changes in both solution and solid phases during precipitation. In the present study, a multimodal approach integrating UV-Vis imaging, light microscopy and Raman spectroscopy was developed for characterization of piroxi-cam supersaturation, precipitation and dissolution in a flow-through setup. A solution of piroxicam dissolved in 1-methyl-2-pyrrolidinone was injected into a flowing aqueous environment (pH 7.4), causing piroxicam to precipitate. Imaging at 405 and 280 nm monitored piroxicam concentration distributions during precipitation and revealed different supersaturation levels dependent on the initial concentration of the piroxicam solution. The combination with imaging at 525 nm, light microscopy and Raman spectroscopy measurements demonstrated concentration-dependent precipitation and the formation, growth, and dissolution of individual particles. Results emphasize the importance of the specific hydrodynamic conditions on the piroxicam precipitation. The approach used may facilitate comprehensive understanding of drug precipitation and dissolution processes and may be developed further into a basic tool for formulation screening and development.
- 10 May 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (11) , 6413-6418
UV–vis Imaging of Piroxicam Supersaturation, Precipitation, and Dissolution in a Flow-Through Setup
Evaluation of drug precipitation is important in order to address challenges regarding low and variable bioavail-ability of poorly water-soluble drugs, to assess potential risk of patient safety with infusion therapy and to explore injectable in situ suspension-forming drug delivery systems. Generally, drug precipitation is assessed in vitro through solution concentra-tion analysis methods. Dual-wavelength UV-Vis imaging is a novel imaging technique which may provide an opportunity for simultaneously monitoring changes in both solution and solid phases during precipitation. In the present study, a multimodal approach integrating UV-Vis imaging, light microscopy and Raman spectroscopy was developed for characterization of piroxi-cam supersaturation, precipitation and dissolution in a flow-through setup. A solution of piroxicam dissolved in 1-methyl-2-pyrrolidinone was injected into a flowing aqueous environment (pH 7.4), causing piroxicam to precipitate. Imaging at 405 and 280 nm monitored piroxicam concentration distributions during precipitation and revealed different supersaturation levels dependent on the initial concentration of the piroxicam solution. The combination with imaging at 525 nm, light microscopy and Raman spectroscopy measurements demonstrated concentration-dependent precipitation and the formation, growth, and dissolution of individual particles. Results emphasize the importance of the specific hydrodynamic conditions on the piroxicam precipitation. The approach used may facilitate comprehensive understanding of drug precipitation and dissolution processes and may be developed further into a basic tool for formulation screening and development.
- 1 January 2018
- Published by Elsevier in Analytica Chimica Acta
- Vol. 999, 27-36
Continuous electromembrane extraction coupled with mass spectrometry – Perspectives and challenges
- 1 January 2018
- Published by Elsevier in Analytica Chimica Acta
- Vol. 999, 27-36
Continuous electromembrane extraction coupled with mass spectrometry – Perspectives and challenges
- 1 August 2017
- Published by Elsevier in Analytica Chimica Acta
- Vol. 983, 121-129
Direct coupling of electromembrane extraction to mass spectrometry - Advancing the probe functionality toward measurements of zwitterionic drug metabolites
- 1 August 2017
- Published by Elsevier in Analytica Chimica Acta
- Vol. 983, 121-129
Direct coupling of electromembrane extraction to mass spectrometry - Advancing the probe functionality toward measurements of zwitterionic drug metabolites